ERIS
ERIS LIFESCIENCES LIMITED
Each stock's 10,000-path forecast, rendered as light.
ERIS LIFESCIENCES LIMITED (ERIS) Stock Analysis & Case Study
Is ERIS a good buy? The data-driven verdict.
ERIS LIFESCIENCES LIMITED (ERIS) trades at ₹1,382,on the numbers it mixed signals, a Downstox Snapshot Score of 54/100.
On the numbers, ERIS LIFESCIENCES LIMITED (ERIS) mixed signals, a Downstox Snapshot Score of 54/100, weighing premium at 29.2× earnings, ROE of 18.7%, a 58% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ERIS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How ERIS ranks against the 2,373 companies in our screener
- ERIS's market cap of 19,158 Cr ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ERIS's book value of ₹282 ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ERIS's promoter holding of 54.1% ranks in the 40th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ERIS's 3-year profit (PAT) growth of 19.0% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ERIS's 3-year revenue growth of 23.0% ranks in the 78th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ERIS's debt-to-equity ratio of 0.60x is lower than 30% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is ERIS overvalued? ERIS P/E vs peers
ERIS trades at 29.2× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
ERIS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 8.9y of ERIS history (9%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ERIS 2027 | ₹965 | ₹1,477 | ₹2,259 | +7% |
| ERIS 2028 | ₹868 | ₹1,577 | ₹2,867 | +14% |
| ERIS 2029 | ₹811 | ₹1,685 | ₹3,501 | +22% |
| ERIS 2030 | ₹769 | ₹1,800 | ₹4,213 | +30% |
| ERIS 2031 | ₹742 | ₹1,923 | ₹4,987 | +39% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ERIS goes up, or doubles?
The bull case for ERIS
- ERIS's return on equity of 18.7% ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹3,501.
The bear case & risks
- ERIS's P/E of 29.2x is lower than 47% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹811.
ERIS volatility & expected range, how bumpy is the ride?
Over the last 8.9 years ERIS compounded at 9%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹965-₹2,259, the honest backbone behind any single price target.
ERIS price forecast, the full 60-month probability fan
ERIS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ERIS hits common targets within the simulated horizon?
Full multi-horizon detail on the ERIS price target & forecast page.
ERIS Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. ERIS scores 6/8, mixed financial health.
ERIS MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy ERIS with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 30.07% | 3.3× |
| Zerodha | 30.04% | 3.3× |
| Groww | 30.16% | 3.3× |
| Dhan | 30.04% | 3.3× |
| Kotak NeoCHEAPEST | 30.03% | 3.3× |
| Paytm Money | 30.18% | 3.3× |
| Pocketful | 30.17% | 3.3× |
| Fyers | 31.25% | 3.2× |
| Anand Rathi | 30.04% | 3.3× |
| Bajaj Broking | 31.00% | 3.2× |
| Share India | 30.16% | 3.3× |
Compare every broker on the ERIS MTF page.
About ERIS LIFESCIENCES LIMITED: sector, index & market-cap context
ERIS LIFESCIENCES LIMITED (ERIS) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹19,158 Cr. See more stocks on our screener.
How the ERIS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of ERIS LIFESCIENCES LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ERIS analysis, FAQs
Is ERIS LIFESCIENCES LIMITED (ERIS) a good buy?
On the numbers, ERIS LIFESCIENCES LIMITED (ERIS) mixed signals, a Downstox Snapshot Score of 54/100, weighing premium at 29.2× earnings, ROE of 18.7%, a 58% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ERIS overvalued or undervalued?
ERIS trades at 29.2× earnings, premium versus the ~22× long-run Nifty average.
What is the ERIS share price target for 2031?
ERIS's probability-weighted 2031 median target is ₹1,923, with an 80% range of ₹742-₹4,987 (10,000-path Monte-Carlo).
What is the probability ERIS doubles in 5 years?
The modelled probability of ERIS reaching ₹2,765 (2×) within 5 years is 31%.
What is the bull case for ERIS?
ERIS's return on equity of 18.7% ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in ERIS?
ERIS's P/E of 29.2x is lower than 47% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.